Adavium

About Adavium

Adavium Medical, founded in 2011 by Fred Aslan, operates as a significant player within the Brazilian healthcare market. The company was established with the goal of becoming a leading medical equipment and diagnostics entity in Brazil. This vision is rooted in the founder's background; Fred Aslan holds an M.D. from Yale and an MBA from Harvard and transitioned from a venture capital role at Venrock to entrepreneurship, driven by his Brazilian heritage and healthcare expertise.

The firm's business model is twofold, addressing distinct segments of the market. It serves as a commercial partner and distributor for international companies with premium, high-tech medical products, making them available to early adopters in Brazil. Concurrently, Adavium develops and manufactures its own line of proprietary products. These are specifically designed to be affordable, targeting the large "long-tail" segment of the Brazilian market that requires high-quality but cost-effective healthcare solutions. This dual strategy allows the company to cater to a broad spectrum of customers, from high-end clinics to those with limited purchasing power.

Adavium operates through two primary divisions: medical devices and clinical diagnostics. The medical devices unit focuses on equipment for specialties such as aesthetics, dermatology, plastic surgery, vascular surgery, and gynecology. The clinical diagnostics division supplies equipment and reagents to clinical laboratories and hospitals. A key milestone in the company's history was in April 2016, when, then known as ADVANCE Medical, it acquired Alka Tecnologia and Hemogram Industria e Comercio, two major Brazilian clinical diagnostic companies. This move, supported by a $21 million Series C financing round from investors including Venrock and Aberdare Ventures, was instrumental in positioning Adavium as the largest Brazilian company in its field based on sales and customer numbers.